Nymox Pharmaceutical Stock Price (NASDAQ:NYMX)

Add to My Stocks
$3.5 $0.03 (0.85%) NYMX stock closing price Feb 24, 2017 (Closing)
Nymox Pharmaceutical
24 FEB 2017
amigobulls logo
NYMX hand_up
NYMX vs S&P 500
Closing Price: Feb 24, 2017
$3.5 ( -0.85%)
S&P 500
2367.3 ( 0.15%)
52 Week Price Range
1 Year Return: 38.98%
Q3 Growth*
Profitable ?
net image
2016 Q3 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Nymox Pharmaceutical Snapshot Video

2 5 2

NYMX Stock Details

Prev Close* : $3.53
Market Cap:
Day Low: $3.45
52 Week Low: $1.62
Open: $3.55
Volume: 133008
Day High: $3.6
52 Week High: $5.79

Latest Stock Market News

Latest Articles

Nymox Pharmaceutical News - From Partners

NYMX Stockcharts

View NYMX PE ratio, PS ratio stocks charts and compare with peers.
NYMX Chart
Note: Compare Nymox Pharmaceutical stock price history with the index and industry peers.

Nymox Pharmaceutical Valuation

PS ratio (
price to sales ratio

Nymox Pharmaceutical Financial Ratios

Asset Turnover
Receivables Turnover

NYMX Industry Peers

Company Price Change (%)
Pharming Group (PHGUF)0.340.01 (3.03%)
Dynavax Technologies (DVAX)4.050.1 (2.53%)
Vascular Biogencis (VBLT)5.60.05 (0.88%)
Mirati Therapeutics (MRTX)5.60.1 (1.75%)
Baxalta (BXLT)46.020.18 (0.39%)
Regeneron Pharma (REGN)361.010.05 (0.01%)
Alexion Pharma (ALXN)131.541.1 (0.84%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Incyte (INCY)131.219.26 (7.59%)
Sarepta Therapeutics (SRPT)32.021.87 (6.2%)
Stemline Therapeutics (STML)6.850.4 (6.2%)
Bluebird Bio (BLUE)823.7 (4.73%)
Puma Biotech (PBYI)36.21.5 (4.32%)
Sangamo BioSciences (SGMO)40.15 (3.9%)
Epizyme (EPZM)12.150.45 (3.85%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 25, 2017
CompanyPriceChange (%)
Achillion Pharma (ACHN)3.860.38 (8.96%)
Chromadex (CDXC)2.740.13 (4.53%)
Idera Pharma (IDRA)1.670.06 (3.47%)
Inovio Pharma (INO)6.680.22 (3.19%)
VIVUS (VVUS)1.140.03 (2.56%)
Ligand Pharma (LGND)100.382.46 (2.39%)
Compugen (CGEN)4.30.1 (2.27%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 25, 2017

Nymox Pharmaceutical Financial Statements

income statement20152014201320122011
Net Sales Or Revenues2.76M2.94M3.35M3.07M3.11M
Net Income-17.88M-4.59M-4.9M-7.62M-9.65M
Total Operating Expense20.25M7.49M7.74M10.41M12.44M
view Nymox Pharmaceutical Corporation income statement
balance sheet20152014201320122011
Total Assets0.71M1.42M0.96M1.75M6.37M
Total Liabilities3.46M5.6M7.02M9.19M11.57M
Shareholders Equity-2.75M-4.18M-6.05M-7.44M-5.19M
view Nymox Pharmaceutical Corporation balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities-1.74M-2.3M-2.12M-2.64M-4.5M
Net Cash From (Used By) Operating Activities-3.75M-5.51M-6.71M-8.3M-10.13M
Increase (Decrease) In Prop Plant And Equipment---0.01M--0.02M
view Nymox Pharmaceutical Corporation cashflow statement

Nymox Pharmaceutical Stock Message Board

As of last trading day, Nymox Pharmaceutical stock price was 3.5. Stock price or share price can be used to find the total market value of a company. Nymox Pharmaceutical market cap stands at 163.04M as of 24 Feb, 2017. Nymox Pharmaceutical valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The terms stocks and shares mean the same thing. For Ex: Nymox Pharmaceutical stock price and Nymox Pharmaceutical share price mean the same thing. 133008 NYMX shares were traded yesterday, and Nymox Pharmaceutical stock chart shows that the NYMX stock quote hit a day high of 3.6 and day low of 3.45. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Nymox Pharmaceutical stock price history, gives the entire historical data for NYMX stock.